Q3 2016 Holdings
Filed 2016-11-14 | 88 holdings | $43.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $9.5M | 400,000 | 21.8% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $7.9M | 1,800,000 | 18.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $6.4M | 200,000 | 14.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $5.6M | 60,000 | 12.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $4.7M | 15,000 | 10.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $4.5M | 175,000 | 10.3% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $2.7M | 300,000 | 6.2% |
| Conmed Corp(CNMD) | COM | 207410101 | $1.8M | 45,000 | 4.1% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $49.7K | 750,000 | 0.1% |
| Ishares TR(IBB)Put | NASDQ BIOTEC ETF | 464287556 | $28.9K | 100,000 | 0.1% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $27.9K | 225,000 | 0.1% |
| Sarepta Therapeutics Inc(SRPT)Put | COM | 803607100 | $24.6K | 400,000 | 0.1% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $21.5K | 350,000 | 0.0% |
| Biogen Inc(BIIB)Call | COM | 09062X103 | $20.3K | 65,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $18.0K | 500,000 | 0.0% |
| Zimmer Biomet Hldgs Inc(ZBH) | COM | 98956P102 | $16.3K | 125,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $14.7K | 120,000 | 0.0% |
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $14.0K | 210,000 | 0.0% |
| GW Pharmaceuticals PLCCall | ADS | 36197T103 | $13.3K | 100,000 | 0.0% |
| Abbott Labs(ABT) | COM | 002824100 | $12.7K | 300,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR)Call | COM | 00771V108 | $11.3K | 300,000 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $10.9K | 435,000 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $10.8K | 200,000 | 0.0% |
| Boston Scientific Corp(BSX)Call | COM | 101137107 | $10.7K | 450,000 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $10.5K | 100,000 | 0.0% |
| Wright MED Group N V | ORD SHS 0.03 PAR | N96617118 | $10.4K | 425,000 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $10.2K | 85,000 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $10.1K | 150,000 | 0.0% |
| Merck & Co Inc(MRK)Call | COM | 58933Y105 | $9.4K | 150,000 | 0.0% |
| Ophthotech CorpCall | COM | 683745103 | $9.2K | 200,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $9.2K | 150,000 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $9.1K | 250,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $8.1K | 175,000 | 0.0% |
| Celgene Corp(CELG)Call | COM | 151020104 | $7.8K | 75,000 | 0.0% |
| Cynosure Inc | CL A | 232577205 | $7.6K | 150,000 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $7.5K | 375,000 | 0.0% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $7.1K | 575,000 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $6.8K | 825,000 | 0.0% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $6.7K | 750,000 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $6.7K | 250,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $6.5K | 2,000,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $6.3K | 60,000 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $5.6K | 400,000 | 0.0% |
| Retrophin Inc | COM | 761299106 | $5.6K | 250,000 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS)Call | COM | 462222100 | $5.5K | 150,000 | 0.0% |
| Qiagen NV(QGEN) | REG SHS | N72482107 | $5.5K | 200,000 | 0.0% |
| Horizon Pharma PLCCall | SHS | G4617B105 | $5.4K | 300,000 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $5.2K | 250,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $4.7K | 125,000 | 0.0% |
| Entellus MED Inc | COM | 29363K105 | $4.4K | 200,000 | 0.0% |